Literature DB >> 7908196

Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.

T Tominaga1, H Suzuki, H Mizuno, M Kouno, M Suzuki, Y Kato, A Sato, K Okabe, M Miyashita.   

Abstract

We investigated the significance of assaying plasma glutamine and glutamate concentrations in various liver diseases. Comparison was made with an aminogram in non-alcoholic liver disease. In alcoholic liver diseases, the plasma glutamate concentration showed a statistically significant elevation compared to the value in non-alcoholic liver diseases. In contrast, the plasma glutamine concentration was elevated in non-alcoholic liver diseases but showed no elevation in alcoholic liver diseases. The glutamate (Glu)/glutamine (Gln) ratio and plasma gamma-GT level correlated well in patients of alcoholic liver diseases. The Glu/Gln ratio became normal after alcohol abstinence. The results suggest that measuring the plasma concentrations of glutamine and glutamate may be a useful method to estimate the pathophysiological state of patients with alcoholic liver diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7908196     DOI: 10.1093/alcalc/28.supplement_1a.103

Source DB:  PubMed          Journal:  Alcohol Alcohol Suppl        ISSN: 1358-6173


  7 in total

1.  Glutamate contributes to alcohol hepatotoxicity by enhancing oxidative stress in mitochondria.

Authors:  Vera V Teplova; Alexey G Kruglov; Leonid I Kovalyov; Anna B Nikiforova; Nadezhda I Fedotcheva; John J Lemasters
Journal:  J Bioenerg Biomembr       Date:  2017-05-06       Impact factor: 2.945

2.  Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis.

Authors:  Won-Mook Choi; Hee-Hoon Kim; Myung-Ho Kim; Resat Cinar; Hyon-Seung Yi; Hyuk Soo Eun; Seok-Hwan Kim; Young Jae Choi; Young-Sun Lee; So Yeon Kim; Wonhyo Seo; Jun-Hee Lee; Young-Ri Shim; Ye Eun Kim; Keungmo Yang; Tom Ryu; Jung Hwan Hwang; Chul-Ho Lee; Hueng-Sik Choi; Bin Gao; Won Kim; Sang Kyum Kim; George Kunos; Won-Il Jeong
Journal:  Cell Metab       Date:  2019-08-29       Impact factor: 27.287

3.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Authors:  Jonathan Barr; Mercedes Vázquez-Chantada; Cristina Alonso; Miriam Pérez-Cormenzana; Rebeca Mayo; Asier Galán; Juan Caballería; Antonio Martín-Duce; Albert Tran; Conrad Wagner; Zigmund Luka; Shelly C Lu; Azucena Castro; Yannick Le Marchand-Brustel; M Luz Martínez-Chantar; Nicolas Veyrie; Karine Clément; Joan Tordjman; Philippe Gual; José M Mato
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

4.  Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease.

Authors:  Bei Gao; Yixin Zhu; Nan Gao; Weishou Shen; Peter Stärkel; Bernd Schnabl
Journal:  Metabolites       Date:  2021-11-10

5.  Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis.

Authors:  Hussam Murad; Haythum Tayeb; Mahmoud Mosli; Misbahuddin Rafeeq; Mohammed Basheikh
Journal:  Int J Gen Med       Date:  2021-11-24

Review 6.  Blood glutamate scavenging: insight into neuroprotection.

Authors:  Akiva Leibowitz; Matthew Boyko; Yoram Shapira; Alexander Zlotnik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208

7.  Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men.

Authors:  Sei Harada; Toru Takebayashi; Ayako Kurihara; Miki Akiyama; Asako Suzuki; Yoko Hatakeyama; Daisuke Sugiyama; Kazuyo Kuwabara; Ayano Takeuchi; Tomonori Okamura; Yuji Nishiwaki; Taichiro Tanaka; Akiyoshi Hirayama; Masahiro Sugimoto; Tomoyoshi Soga; Masaru Tomita
Journal:  Environ Health Prev Med       Date:  2015-10-12       Impact factor: 3.674

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.